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In the face of rising HF morbidity, mortality, and costs, there have been important contemporary advances in both pharmacological (5) and nonpharmacological therapies (6) , although their application and benefit are often restricted to a subset of patients (7) . In this context, given the long-recognized relationship between autonomic nervous system (ANS) function and HF, there is increasing interest in ANS modulation as a therapeutic modality. In this review, we highlight the anatomy of the ANS and its role in the pathophysiology of HF, as well as metrics of its assessment.
We then review contemporary nonpharmacological ANS modulation therapies in HF before commenting on novel technologies and strategies on the horizon.
ANATOMY, REFLEXES, AND REGULATION OF THE ANS
In its most reductive form, the ANS primarily com- The ANS is further modulated through bidirectional feedback from the renin-angiotensin-aldosterone system (RAAS). For example, reduced renal perfusion (reflective of reduced cardiac output) is associated with release of renin and downstream synthesis of angiotensin II (ATII), which functions centrally to increase SNS activity (14, 15) while also inhibiting baroreflex-mediated suppression of SNS tone (16, 17) .
Inversely, increased SNS output leads to increased renin secretion (14) . (increased apoptosis, abnormal calcium handling, increased interstitial fibrosis) (23) (24) (25) . In addition to abnormalities of the SNS, withdrawal and attenuation of PNS input has also been implicated in the pathogenesis of HF (12) . PNS alterations include reduced vagal ganglionic activity as well as loss of PNS receptor density and neurotransmitter activity (12, 26) .
Sympathovagal imbalance in HF, including loss of PNS inhibition of SNS reflex arcs (27) (28) (29) , has been associated with increased resting HR and worse clinical outcomes in HF (30) . Reduced PNS activity may further contribute to HF pathogenesis through dysregulation of NO signaling (12, 31, 32) as well as loss of PNS inhibition of inflammatory cytokine release (33, 34) and RAAS activation (35) .
Electrophysiologically, HF is associated with neuronal and ionic channel remodeling (36, 37) as well as abnormal SNS and PNS discharges (38) . SNS- Table 1) . Historically, SNS activity was measured via plasma NE levels utilizing radioimmunoassay of regional venous or arterial blood (21, 42, 43) .
Unfortunately, plasma NE levels are at best a crude assessment of SNS function subject to the heterogeneity of synthesis, reuptake and clearance of NE in different tissue beds (44, 45) . More direct quantification of SNS activity includes microneurography, which measures post-ganglionic SNS neuronal firing within cutaneous or muscular vasculature (46, 47) , although this is resource intensive and subject to measurement variability (48) . 
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